Complete response of lung metastases caused by prostatic cancer after chronic administration of a gonadotropin-releasing hormone analog, buserelin (HOE 766)
- 1 January 1987
- journal article
- research article
- Published by Wiley in The Prostate
- Vol. 10 (1) , 19-24
- https://doi.org/10.1002/pros.2990100105
Abstract
A stage D2 prostate cancer patient with biopsy-proven lung metastases and negative work-up for metastases is discussed. Treatment consisted of hormonai therapy in the form of chronic administration of an analog of gonadotropin-releasing hormone (GnRH-A), Buserelin, with follow-up for 24 months. The complete response of the patient to GnRH-A therapy provides an interesting and unusual case in the understanding of the biological behavior of prostate cancer.Keywords
This publication has 20 references indexed in Scilit:
- Objective response and disease outcome in 59 patients with stage D2 prostatic cancer treated with either buserelin or orchiectomy Disease aggressivity and its association with response and outcomeUrology, 1986
- Long‐term follow‐up of patients with advanced prostatic carcinoma treated with either buserelin (HOE 766) or orchiectomy: Classification of variables associated with disease outcomeThe Prostate, 1985
- CLEARANCE OF LUNG METASTASES OF PROSTATE CARCINOMA AFTER TREATMENT WITH LH-RH AGONISTThe Lancet, 1984
- Gonadotropin‐releasing hormone agonistic analogues in the treatment of advanced prostatic carcinomaThe Prostate, 1982
- Transabdominal ultrasonography in the evaluation of patients with advanced prostatic carcinoma: Effects of castration and of chronic administration of a gonadotropin releasing hormone agonistic analogueThe Prostate, 1982
- Long-Term Survivor of Prostatic Carcinoma with Lung MetastasesJournal of Urology, 1981
- Lung metastases in prostatic carcinomaUrology, 1974
- An Unusual Remission of Prostatic Carcinoma With Pulmonary MetastasesJournal of Urology, 1969
- Pulmonary Metastases from Carcinoma of the Prostate: Incidence and Case Report of a Long RemissionJournal of Urology, 1965
- ENDOCRINE CONTROL OF PROSTATIC CARCINOMAJAMA, 1950